Stage IIIB Uveal Melanoma AJCC v7
3 clinical trials · Condition
◉ Watch Stage IIIB Uveal Melanoma AJCC v7
| Record | Firm | Date |
|---|---|---|
| Neoadjuvant and Adjuvant Checkpoint Blockade (NCT02519322) | M.D. Anderson Cancer Center | 2016-02-02 |
| Cabozantinib-S-Malate Compared With Temozolomide or Dacarbazine in Treating Patients With Metastatic Melanoma of the Eye That Cannot Be Removed by Surgery (NCT01835145) | National Cancer Institute (NCI) | 2013-07-31 |
| Sargramostim, Vaccine Therapy, or Sargramostim and Vaccine Therapy in Preventing Disease Recurrence in Patients With Melanoma That Has Been Removed By Surgery (NCT01989572) | National Cancer Institute (NCI) | 2000-02-23 |
Track Stage IIIB Uveal Melanoma AJCC v7 automatically
Every clearance here is in the API, with alerts when new ones post.